Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.

Details

Ressource 1Download: BIB_7C3F723ADF8F.P001.pdf (325.02 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_7C3F723ADF8F
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Whole brain radiotherapy with a conformational external beam radiation boost for lung cancer patients with 1-3 brain metastasis: a multi institutional study.
Journal
Radiation Oncology
Author(s)
Casanova Nathalie, Mazouni Zohra, Bieri Sabine, Combescure Christophe, Pica Alessia, Weber Damien C.
ISSN
1748-717X[electronic], 1748-717X[linking]
Publication state
Published
Issued date
2010
Volume
5
Pages
13
Language
english
Abstract
BACKGROUND: To determine the outcome of patients with brain metastasis (BM) from lung cancer treated with an external beam radiotherapy boost (RTB) after whole brain radiotherapy (WBRT). METHODS: A total of 53 BM patients with lung cancer were treated sequentially with WBRT and RTB between 1996 and 2008 according to our institutional protocol. Mean age was 58.8 years. The median KPS was 90. Median recursive partitioning analysis (RPA) and graded prognostic assessment (GPA) grouping were 2 and 2.5, respectively. Surgery was performed on 38 (71%) patients. The median number of BM was 1 (range, 1-3). Median WBRT and RTB combined dose was 39 Gy (range, 37.5-54). Median follow-up was 12.0 months. RESULTS: During the period of follow-up, 37 (70%) patients died. The median overall survival (OS) was 14.5 months. Only 13 patients failed in the brain. The majority of patients (n = 29) failed distantly. The 1-year OS, -local control, extracranial failure rates were 61.2%, 75.2% and 60.8%, respectively. On univariate analysis, improved OS was found to be significantly associated with total dose (< or = 39 Gy vs. > 39 Gy; p < 0.01), age < 65 (p < 0.01), absence of extracranial metastasis (p < 0.01), GPA > or = 2.5 (p = 0.01), KPS > or = 90 (p = 0.01), and RPA < 2 (p = 0.04). On multivariate analysis, total dose (p < 0.01) and the absence of extracranial metastasis (p = 0.03) retained statistical significance. CONCLUSIONS: The majority of lung cancer patients treated with WBRT and RTB progressed extracranially. There might be a subgroup of younger patients with good performance status and no extracranial disease who may benefit from dose escalation after WBRT to the metastatic site.
Keywords
Therapy-Oncology-Group, Cerebral Metastases, Stereotactic Radiosurgery, Neurocognitive Function, Prognostic-Factors, Breast-Cancer, Carcinoma, Trial, Chemotherapy, Irradiation
Pubmed
Web of science
Open Access
Yes
Create date
29/03/2010 14:21
Last modification date
20/08/2019 14:37
Usage data